Effect of the Rasayana therapy in cancer treatment
Not Applicable
- Conditions
- Health Condition 1: R64- Cachexia
- Registration Number
- CTRI/2021/05/033756
- Lead Sponsor
- Rasayu Cancer Clinic Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Age greater than 18 yrs
2 All GI cancer patients with history of >5% weight loss in over 6 months
3 Patients who has moderate to severe anorexia Anorexia
4 Performance status â??less than or equal to 2
Exclusion Criteria
1 Patients who are on other conventional medicines to treat anorexia and cachexia like megestrol acetate, corticosteroids, delta-9-tetrahydrocannabinol (THC), antiemetic etc.
2 Patient who is taking other nutritional supplements
3 Life expectancy < 3 months
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 To assess efficacy of Rasayana therapy on body weight and BMI anorexia pre and post therapy <br/ ><br>2 To assess effects on anorexia by using Fact G -ACT (FAAC-VERSION 4)for anorexia <br/ ><br>3 To assess QOL by using FACT G and Physician performance status by ECOG <br/ ><br>4 To assess changes in plasma albumin, CRP, and Glasgow Prognostic Score. <br/ ><br>5 To assess safety and tolerability of Rasayana therapy <br/ ><br> <br/ ><br>Timepoint: Day 0 Day 30 Day 60 Day 90
- Secondary Outcome Measures
Name Time Method 1 To assess effects on anorexia by using Fact G for anorexia and VAS scale <br/ ><br>2 To assess QOL by using FACT G and Physician performance status by ECOG <br/ ><br>3 To assess changes in plasma albumin, CRP, and Glasgow Prognostic Score. <br/ ><br>4 To assess safety and tolerability of Rasayana therapy <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: Day 0 Day 30 Day 60 Day 90